7 withdrawn. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Withdrawn 7 |
| Phase 1 | 2 | Withdrawn 2 |
Follow Blast Crisis: new trials by email Literature Review of Blast Crisis trials Research Report on Blast Crisis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies cyclophosphamide, fludarabine phosphate, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 2 | Withdrawn | University of Medicine and Dentistry of New Jersey | 2014-01-01 | 2016-07-14 | |
| Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia nilotinib, rituximab, cyclophosphamide - B-cell Adult Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia | Phase 2 | Withdrawn | Mayo Clinic | 2012-12-01 | 2015-10-30 | |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 1 / Phase 2 | Withdrawn | University of Nebraska | 2008-09-01 | 2023-08-14 | |
| A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia Imatinib Mesylate, CLAG - Chronic Myeloid Leukemia, Blast Crisis, Acute Myeloid Leukemia | Phase 2 | Withdrawn | University of Cincinnati | 20 | 2007-11-01 | 2008-10-31 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer filgrastim, busulfan, fludarabine phosphate - Anemia, Chronic Myeloproliferative Disorders | Phase 2 | Withdrawn | University of California, San Francisco | 2002-01-01 | 2012-10-02 | |
| Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML amifostine trihydrate, cytarabine, mitoxantrone hydrochloride - Drug/Agent Toxicity by Tissue/Organ, Leukemia | Phase 2 | Withdrawn | Rush University Medical Center | 2001-02-13 | 2023-02-02 | |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2013-02-15 |
Leukemia, Myeloid, Acute (6) · Congenital Abnormalities (4) · Leukemia (4) · Leukemia, Lymphocytic, Chronic, B-Cell (4) · Leukemia, Myeloid, Accelerated Phase (4) · Lymphoma, B-Cell, Marginal Zone (4) · Lymphoma, Follicular (4) · Lymphoma, Mantle-Cell (4) · Lymphoma, Non-Hodgkin (4) · Myelodysplastic Syndromes (4) · Myeloproliferative Disorders (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Burkitt Lymphoma (3) · Leukemia, Myeloid, Chronic-Phase (3)
Bone Marrow Diseases (7) · Carcinogenesis (7) · Cell Transformation, Neoplastic (7) · Chronic Disease (7) · Disease Attributes (7) · Hemic and Lymphatic Diseases (7) · Leukemia, Myeloid (7) · Neoplasms by Histologic Type (7) · Neoplastic Processes (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Hematologic Diseases (6) · Neoplasms (6) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)
Cytarabine (3) · Peripheral Blood Stem Cell Transplantation (3) · Cyclophosphamide (2) · Methotrexate (2) · Mycophenolic Acid (2) · Tacrolimus (2) · Whole-Body Irradiation (2) · fludarabine phosphate (2) · Amifostine (1) · Busulfan (1) · Calcium Dobesilate (1) · Cladribine (1) · Cord Blood Stem Cell Transplantation (1) · Cyclosporine (1) · Cyclosporins (1)
M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Rush University Medical Center (1) · University of California, San Francisco (1) · University of Cincinnati (1) · University of Medicine and Dentistry of New Jersey (1) · University of Nebraska (1)
United States (5)
Aref Al-Kali, M.D. (1) · Jorge Cortes, MD (1) · Patrick Chaftari, MD (1) · Philip D. Bonomi, MD (1) · Rami S Komrokji, MD (1) · Robert Bociek, MD (1) · Roger Strair (1) · Thomas G. Martin, MD (1)
P01CA075606 (1), P30CA036727 (1), P30CA072720 (1)